Expert Review of Pharmacoeconomics and Outcomes Research
Taylor and Francis Ltd.
United Kingdom
journal
SJR by Edition
Subject Categories
- Health PolicyQ3
- Medicine (miscellaneous)Q3
- Pharmacology (medical)Q3
Areas: Medicine
Most published research topics
Source: OpenAlex
Publication Statistics
Documents per Year
Detailed Information
ISSN
1473-7167, 1744-8379
SJR Best Quartile
Q3
Region
Western Europe
Citations per Document (2 years)
2.19
References per Document
45.32
Coverage
2001-2026
Scope
Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points.
Metrics from SCImago Journal Rank 2025. View on SCImago